Pfizer CEO Confident U.S. Advisory Panel Will Greenlight COVID-19 Vaccine Candidate


FILE – In this Feb. 26, 2019 file photo, Albert Bourla, chief executive officer of Pfizer, prepares to testify before the Senate Finance Committee hearing on drug prices, on Capitol Hill in Washington. (AP Photo/Pablo Martinez Monsivais, File)

Pfizer’s chief executive said he’s fully prepared to face the U.S. vaccine advisory panel later this week.

During a briefing Tuesday, Albert Bourla said he expects an “intense meeting” with the panel, but remains confident that the experts will approve of the company’s COVID-19 vaccine candidate.

The Pfizer-BioNtech preventative has already been distributed in small amounts across Britain, but some officials have raised concerns about the extensive care needed to transport the vaccine.

Nevertheless, the company’s CEO remains optimistic.

“…these are experts, they will ask a lot of questions. We have answers, we believe, to every question that they will ask and I think they will vote ‘yes’ given the strength of the data,” Bourla asserted. “And then, it is up to the FDA to conclude the process and give the advise.”

This comes after the FDA released documents detailing how the vaccine candidate has no new safety or efficacy issues.

Comments

Popular posts from this blog

Dr. Vladimir Zelenko has now treated 699 coronavirus patients with 100% success

ORIGIN OF THE AKAN

GARDEN OF EDEN FOUND IN WEST AFRICA

FIVE WAYS A WIFE CAN REST HER HUSBAND ON HER

STEP FOUR: LEARN TO PACKAGE YOURSELF

THE HISTORY AND ORIGIN OF THE ZULU PEOPLE

BRIEF HISTORY OF NKALAHA.

MYSTERY OF IGBO COSMOLOGY

THE ORIGIN AND HISTORY OF UDI by Onyeji Nnaji

THE ORIGIN AND HISTORY OF NSUKKA by Onyeji Nnaji